X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36) 36
humans (30) 30
anti-bacterial agents - therapeutic use (16) 16
critical care medicine (15) 15
infectious diseases (15) 15
medicine & public health (13) 13
ventilator-associated pneumonia (13) 13
research (12) 12
emergency medicine (11) 11
anesthesiology (10) 10
intensive / critical care medicine (10) 10
pain medicine (10) 10
pediatrics (10) 10
pneumology/respiratory system (10) 10
pneumonia (10) 10
drug resistance (9) 9
female (9) 9
in-vitro activity (9) 9
male (9) 9
pharmacology & pharmacy (9) 9
antibiotics (8) 8
hospitals (8) 8
infections (8) 8
intensive care units (8) 8
klebsiella-pneumoniae (8) 8
microbiology (8) 8
anti-bacterial agents - pharmacology (7) 7
microbial sensitivity tests (7) 7
middle aged (7) 7
mortality (7) 7
pseudomonas-aeruginosa (7) 7
adult (6) 6
aged (6) 6
anti-bacterial agents - adverse effects (6) 6
antimicrobial agents (6) 6
care and treatment (6) 6
critically-ill patients (6) 6
drug resistance in microorganisms (6) 6
epidemiology (6) 6
health aspects (6) 6
intensive-care-unit (6) 6
minocycline - analogs & derivatives (6) 6
therapy (6) 6
acinetobacter baumannii (5) 5
bacteria (5) 5
drug resistance, multiple, bacterial (5) 5
drug therapy (5) 5
infection (5) 5
management (5) 5
minocycline - therapeutic use (5) 5
prevention (5) 5
pseudomonas aeruginosa (5) 5
risk factors (5) 5
usage (5) 5
acinetobacter-baumannii (4) 4
adults (4) 4
aged, 80 and over (4) 4
anti-infective agents - therapeutic use (4) 4
antimicrobial resistance (4) 4
bacteremia (4) 4
bacterial infections - drug therapy (4) 4
bacterial pneumonia (4) 4
colistin (4) 4
critical care (4) 4
enterobacteriaceae (4) 4
gram-negative bacterial infections - drug therapy (4) 4
internal medicine (4) 4
klebsiella pneumoniae (4) 4
minocycline - adverse effects (4) 4
mrsa (4) 4
pathogens (4) 4
patient outcomes (4) 4
research article (4) 4
treatment outcome (4) 4
urinary-tract-infections (4) 4
ventilators (4) 4
acinetobacter infections - drug therapy (3) 3
analysis (3) 3
animals (3) 3
anti-bacterial agents - pharmacokinetics (3) 3
antimicrobial activity (3) 3
blood-stream infection (3) 3
carbapenems - therapeutic use (3) 3
colistin - therapeutic use (3) 3
complications and side effects (3) 3
critical illness (3) 3
critically ill (3) 3
cross infection - drug therapy (3) 3
enzymes (3) 3
fosfomycin - therapeutic use (3) 3
greece (3) 3
greece - epidemiology (3) 3
infectious disease (3) 3
influenza (3) 3
intubation (3) 3
klebsiella infections - drug therapy (3) 3
medical research (3) 3
medicine, experimental (3) 3
minocycline - pharmacokinetics (3) 3
minocycline - pharmacology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
INTENSIVE CARE MEDICINE, ISSN 0342-4642, 12/2016, Volume 42, Issue 12, pp. 2055 - 2058
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00134-016-4580-4 
TRANSMISSION | VIRUS | EBOLA | CRITICAL CARE MEDICINE | Travel | Communicable Diseases, Emerging - transmission | Global Health | Disease Outbreaks | Humans
Journal Article
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 10/2017, Volume 43, Issue 10, pp. 1464 - 1475
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2010, Volume 50, Issue 3, pp. 364 - 373
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 09/2017, Volume 77, Issue 13, pp. 1399 - 1412
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2013, Volume 43, Issue 1, pp. 52 - 59
Abstract Fosfomycin is active in vitro against extensively drug-resistant (XDR) and pandrug-resistant (PDR) Pseudomonas aeruginosa and Klebsiella pneumoniae... 
Infectious Disease | Klebsiella | Pseudomonas | Critically ill | XDR | Fosfomycin | PDR | DEFINITION | MORTALITY | INFECTIOUS DISEASES | COMBINATION THERAPY | MICROBIOLOGY | INTRAVENOUS FOSFOMYCIN | K.-PNEUMONIAE | IMPACT | PREDICTORS | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Klebsiella pneumoniae - drug effects | Prospective Studies | Humans | Middle Aged | Minocycline - analogs & derivatives | Critical Illness | Male | Bacterial Proteins - secretion | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Minocycline - adverse effects | Minocycline - therapeutic use | Pseudomonas aeruginosa - enzymology | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Adult | Colistin - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Intensive Care Units | Fosfomycin - therapeutic use | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Fosfomycin - adverse effects | Treatment Outcome | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | beta-Lactamases - secretion | Administration, Intravenous | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Aged | Care and treatment | Pneumonia | Microbiology | Patient outcomes | Analysis | Bacterial pneumonia | Mortality | Bacteria | Drug resistance
Journal Article
Expert Opinion on Drug Metabolism and Toxicology, ISSN 1742-5255, 11/2011, Volume 7, Issue 11, pp. 1459 - 1470
Introduction: As the spread of multidrug-resistant (MDR) and extensive drug-resistant (XDR) organisms constitutes a real threat for patients, new... 
Drugs | Pathogens | Antimicrobial activity | Pharmacodynamics | Pneumonia | Lung | tigecycline | Clinical trials | Antimicrobial agents | Data processing | Intra-abdominal infection | ventilator-associated pneumonia | Drug resistance | Metabolism | Infection | Reviews | Antibiotics | Skin | Pharmacokinetics
Journal Article
Drugs, ISSN 0012-6667, 10/2009, Volume 69, Issue 14, pp. 1879 - 1901
The emergence of multidrug-resistant (MDR) Gram-negative bacilli creates a challenge in the treatment of nosocomial infections. While the pharmaceutical... 
Journal Article
Drugs, ISSN 0012-6667, 10/2009, Volume 69, Issue 14, pp. 1879 - 1901
The emergence of multidrug-resistant (MDR) Gram-negative bacilli creates a challenge in the treatment of nosocomial infections. While the pharmaceutical... 
Journal Article
Monaldi Archives for Chest Disease, ISSN 1122-0643, 10/2019, Volume 89, Issue 3
Nocardia spp. is a genus of Gram-positive bacteria which can cause cutaneous, pleuropulmonary, or disseminated disease. The latter two forms are encountered in... 
Cushing’s syndrome | pituitary adenoma | Nocardia spp | opportunistic infection
Journal Article